Singapore markets closed

STERIS plc (STE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
202.80-3.19 (-1.55%)
As of 04:00PM EDT. Market open.

STERIS plc

70 Sir John Rogerson’s Quay
Dublin 2
Dublin D02 R296
Ireland
353 1 232 2000
https://www.steris.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees17,000

Key executives

NameTitlePayExercisedYear born
Mr. Daniel A. CarestioPresident, CEO & Director1.59MN/A1973
Mr. Michael J. TokichSenior VP & CFO838.61kN/A1969
Mr. John Adam ZangerleSenior VP, General Counsel & Secretary718.45k1.5M1967
Ms. Mary Clare FraserSVP & Chief Human Resources Officer555.75kN/A1970
Mr. Cary L. MajorsSenior Vice President & President of Healthcare615.61kN/A1975
Ms. Karen L. BurtonChief Accounting Officer, VP & ControllerN/AN/A1968
Julie WinterVice President of Investor Relations & Corporate CommunicationsN/AN/AN/A
Ms. Julia K. MadsenSenior Vice President of Life SciencesN/AN/A1965
Mr. Andrew XilasSenior VP & GM of Dental1.44MN/A1965
Kenneth E. KohlerSenior VP & GM of ASTN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Corporate governance

STERIS plc’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 9; Board: 4; Shareholder rights: 8; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.